(Q52211155)
Statements
Potential treatment of Alzheimer disease using cholinergic channel activators (ChCAs) with cognitive enhancement, anxiolytic-like, and cytoprotective properties. (English)
1 reference
Arneric SP
1 reference
Sullivan JP
1 reference
Decker MW
1 reference
Brioni JD
1 reference
Bannon AW
1 reference
Briggs CA
1 reference
Donnelly-Roberts D
1 reference
Radek RJ
1 reference
Marsh KC
1 reference
Kyncl J
1 reference
1 January 1995
1 reference
9 Suppl 2
1 reference
50-61
1 reference